An Agent Not Well MET in Lung Cancer
Dr. Mark Kris reports on 2 studies on MET inhibition in NSCLC that underscore the importance of defining the patient population who would benefit from a targeted therapy. (Source: Medscape Pulmonary Medicine Podcast)
Source: Medscape Pulmonary Medicine Podcast - July 14, 2014 Category: Respiratory Medicine Authors: Medscape Source Type: podcasts
A Legacy of Cures Never Before Attained
Three ASCO presidents chart the course of the Society -- and oncology as a whole -- over the past 50 years, from a tentative first meeting to a global influence for cancer research and practice. (Source: Medscape Pulmonary Medicine Podcast)
Source: Medscape Pulmonary Medicine Podcast - June 23, 2014 Category: Respiratory Medicine Authors: Medscape Source Type: podcasts
Past Presidents Survey ASCO’s First 50 Years
Three ASCO presidents chart the course of the Society -- and oncology as a whole -- over the past 50 years, from a tentative first meeting to a global influence for cancer research and practice. (Source: Medscape Pulmonary Medicine Podcast)
Source: Medscape Pulmonary Medicine Podcast - June 23, 2014 Category: Respiratory Medicine Authors: Medscape Source Type: podcasts
ASCO Presidents Survey 50 Years of Oncology
Three ASCO presidents chart the course of the Society -- and oncology as a whole -- over the past 50 years, from a tentative first meeting to a global influence for cancer research and practice. (Source: Medscape Pulmonary Medicine Podcast)
Source: Medscape Pulmonary Medicine Podcast - June 23, 2014 Category: Respiratory Medicine Authors: Medscape Source Type: podcasts
ASCO ® 2014: Aiming at Cancer’s Achilles Heel
Four leading oncologists discuss the top studies from ASCO 2014 and how immunotherapy is reshaping cancer care and practice. (Source: Medscape Pulmonary Medicine Podcast)
Source: Medscape Pulmonary Medicine Podcast - June 9, 2014 Category: Respiratory Medicine Authors: Medscape Source Type: podcasts
